Patents by Inventor Robert Veltri

Robert Veltri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer
    Publication number: 20110286917
    Abstract: Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.
    Type: Application
    Filed: June 10, 2011
    Publication date: November 24, 2011
    Inventors: Gang An, Robert Veltri
  • Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
    Patent number: 7993830
    Abstract: Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.
    Type: Grant
    Filed: February 12, 2007
    Date of Patent: August 9, 2011
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Gang An, Robert Veltri
  • Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
    Publication number: 20080044416
    Abstract: Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.
    Type: Application
    Filed: February 12, 2007
    Publication date: February 21, 2008
    Inventors: Gang An, Robert Veltri
  • Diagnosis of disease state using mRNA profiles in peripheral leukocytes
    Patent number: 7332270
    Abstract: Disclosed are diagnostic techniques for the detection of human disease states that affect gene expression in peripheral leukocytes. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in the peripheral blood of individuals with such a disease state compared to normal healthy individuals. The invention further relates to methods for detection of protein species that are differentially expressed in the peripheral blood of individuals with such a disease state compared to normal healthy individuals. Genetic probes, antibody probes and methods useful in monitoring the progression and diagnosis of two specific disease states, prostatic cancer and breast cancer, are described.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: February 19, 2008
    Assignee: Urocor, Inc.
    Inventors: David Ralph, Gang An, S. Mark O'Hara, Robert Veltri
  • Biomarkers and targets for diagnosis, prognosis and management of prostate disease, bladder and breast cancer
    Publication number: 20030050470
    Abstract: Disclosed are diagnostic techniques for the detection of human prostate, bladder and breast cancer. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate, bladder and breast cancer are described. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in prostate, bladder and breast cancer compared to normal human prostate, benign prostatic hyperplasia, or normal bladder or breast tissue.
    Type: Application
    Filed: October 10, 2001
    Publication date: March 13, 2003
    Applicant: UroCor, Inc.
    Inventors: Gang An, S. Mark O'Hara, David Ralph, Robert Veltri
  • Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
    Publication number: 20030017472
    Abstract: Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.
    Type: Application
    Filed: September 25, 2001
    Publication date: January 23, 2003
    Applicant: UROCOR, INC.
    Inventors: Gang An, Robert Veltri
  • Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
    Publication number: 20020068281
    Abstract: Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.
    Type: Application
    Filed: January 2, 2001
    Publication date: June 6, 2002
    Applicant: UROCOR, INC.
    Inventors: Gang An, Robert Veltri
  • Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
    Patent number: 6369195
    Abstract: Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: April 9, 2002
    Assignee: Urocor, Inc.
    Inventors: Gang An, Robert Veltri
  • Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
    Patent number: 6218529
    Abstract: Disclosed are diagnostic techniques for the detection of human prostate, bladder and breast cancer. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate, bladder and breast cancer are described. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in prostate, bladder and breast cancer compared to normal human prostate, benign prostatic hyperplasia, or normal bladder or breast tissue.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: April 17, 2001
    Assignee: UroCor, Inc.
    Inventors: Gang An, S. Mark O'Hara, David Ralph, Robert Veltri
  • Diagnosis of disease state using MRNA profiles in peripheral leukocytes
    Patent number: 6190857
    Abstract: Disclosed are diagnostic techniques for the detection of human disease states that affect gene expression in peripheral leukocytes. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in the peripheral blood of individuals with such a disease state compared to normal healthy individuals. The invention further relates to methods for detection of protein species that are differentially expressed in the peripheral blood of individuals with such a disease state compared to normal healthy individuals. Genetic probes, antibody probes and methods useful in monitoring the progression and diagnosis of two specific disease states, prostatic cancer and breast cancer, are described.
    Type: Grant
    Filed: March 24, 1998
    Date of Patent: February 20, 2001
    Assignee: Urocor, Inc.
    Inventors: David Ralph, Gang An, S. Mark O'Hara, Robert Veltri
  • Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
    Patent number: 6156515
    Abstract: Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: December 5, 2000
    Assignee: Urocor, Inc.
    Inventors: Gang An, Robert Veltri
  • Biomarkers and targets for diagnosis, prognosis and management of prostate disease
    Patent number: 5882864
    Abstract: Disclosed are diagnostic techniques for the detection of human prostate cancer. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in prostate cancer compared to normal human prostate or benign prostatic hyperplasia.
    Type: Grant
    Filed: July 31, 1996
    Date of Patent: March 16, 1999
    Assignee: Urocor Inc.
    Inventors: Gang An, S. Mark O'Hara, David Ralph, Robert Veltri
  • Pharmaceutically useful Michael addition products of unsaturated aldehydes and ketones and ascorbic acid
    Patent number: 5098933
    Abstract: Michael addition products of ascorbic acid and selected unsaturated aldehydes and ketones are useful as immunomodulators in mammals.
    Type: Grant
    Filed: September 25, 1990
    Date of Patent: March 24, 1992
    Assignee: Theracel Corporation
    Inventors: Robert Veltri, Gabor B. Fodor